DWM
IONS icon

Dynasty Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Dynasty Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
14,080
+90
+0.6% +$7.1K 0.01% 179
2025
Q4 		$1.11M Sell
13,990
-351
-2% -$26.4K 0.01% 178
2025
Q3 		$938K Buy
+14,341
New +$700K 0.01% 170

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynasty Wealth Management's IONS Position: Q1 2026 in Review

Dynasty Wealth Management increased its Ionis Pharmaceuticals (IONS) stake by 0.64% in Q1 2026, buying an estimated $7.1K and bringing the position to 14,080 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #179.

Dynasty Wealth Management first reported a position in IONS in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.11M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Dynasty Wealth Management held 14,080 shares of Ionis Pharmaceuticals worth $1.06M as of Q1 2026.
  • Dynasty Wealth Management bought 90 Ionis Pharmaceuticals shares in Q1 2026, an estimated $7.1K.
  • Ionis Pharmaceuticals made up 0.01% of Dynasty Wealth Management's portfolio in Q1 2026, its #179 holding.
  • Dynasty Wealth Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Dynasty Wealth Management's Ionis Pharmaceuticals position peaked at $1.11M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.